Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1998 6
1999 5
2000 7
2001 13
2002 10
2003 17
2004 19
2005 25
2006 17
2007 20
2008 17
2009 18
2010 17
2011 15
2012 24
2013 18
2014 30
2015 27
2016 36
2017 25
2018 18
2019 20
2020 26
2021 30
2022 22
2023 19
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

451 results

Results by year

Filters applied: . Clear all
Page 1
Coronary In-Stent Restenosis: Predictors and Treatment.
Ullrich H, Olschewski M, Münzel T, Gori T. Ullrich H, et al. Dtsch Arztebl Int. 2021 Sep 24;118(38):637-644. doi: 10.3238/arztebl.m2021.0254. Dtsch Arztebl Int. 2021. PMID: 34379053 Free PMC article. Review.
BACKGROUND: Despite the use of modern drug-eluting stents (DES), in-stent restenosis (ISR) may still occur in as many as 2-10% of percutaneous coronary interventions (PCI) in certain lesion/patient subsets. ISR causes increased morbidity after stent implantat …
BACKGROUND: Despite the use of modern drug-eluting stents (DES), in-stent restenosis (ISR) may still occur in as many as 2-10% …
Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics.
Muramatsu T, Kozuma K, Tanabe K, Morino Y, Ako J, Nakamura S, Yamaji K, Kohsaka S, Amano T, Kobayashi Y, Ikari Y, Kadota K, Nakamura M; Task Force of the Japanese Association of Cardiovascular Intervention, Therapeutics (CVIT). Muramatsu T, et al. Cardiovasc Interv Ther. 2023 Apr;38(2):166-176. doi: 10.1007/s12928-023-00921-2. Epub 2023 Feb 27. Cardiovasc Interv Ther. 2023. PMID: 36847902 Free PMC article. Review.
The absence of foreign material can reduce the risk of very late stent failure, improve the ability to perform bypass-graft surgery, and reduce the need for long-term dual antiplatelet therapy, potentially reducing associated bleeding complications. ...Currently, th …
The absence of foreign material can reduce the risk of very late stent failure, improve the ability to perform bypass-graft surgery, …
Management of in-stent restenosis.
Alfonso F, Coughlan JJ, Giacoppo D, Kastrati A, Byrne RA. Alfonso F, et al. EuroIntervention. 2022 Jun 3;18(2):e103-e123. doi: 10.4244/EIJ-D-21-01034. EuroIntervention. 2022. PMID: 35656726 Free PMC article.
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI). ...We then move on to detail the evidence base underpinning the various therapeutic strategies for ISR before finishing with a prop …
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI) …
Treatment of coronary artery in-stent restenosis.
Kokkinidis DG, Waldo SW, Armstrong EJ. Kokkinidis DG, et al. Expert Rev Cardiovasc Ther. 2017 Mar;15(3):191-202. doi: 10.1080/14779072.2017.1284588. Epub 2017 Jan 31. Expert Rev Cardiovasc Ther. 2017. PMID: 28116914 Review.
Although drug-eluting stents (DES) have significantly reduced the incidence and prevalence of coronary in-stent restenosis (ISR), ISR still occurs in approximately 10% of patients in real-world practice. ...This article reviews the presentation, pathophysiology, and …
Although drug-eluting stents (DES) have significantly reduced the incidence and prevalence of coronary in-stent restenosis (IS …
Evaluation and management of drug-eluting stent in-stent restenosis.
Parfrey S, Siu V, Graham JJ, Vijayaraghavan R, Li C, Pang J, Kalra S, Džavík V, Wijeysundera HC, Bagai A; from the University of Toronto CTO Collaborative. Parfrey S, et al. Curr Opin Cardiol. 2023 Sep 1;38(5):433-440. doi: 10.1097/HCO.0000000000001073. Epub 2023 Jul 13. Curr Opin Cardiol. 2023. PMID: 37477129 Review.
PURPOSE OF REVIEW: In-stent restenosis (ISR) is the most common cause of stent failure. ...Individualized treatment may include high-pressure balloon angioplasty alone, cutting or scoring balloons, intravascular lithotripsy, atheroablative therapies an …
PURPOSE OF REVIEW: In-stent restenosis (ISR) is the most common cause of stent failure. ...Individualized treatment may …
Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.
Yamamoto K, Sato T, Salem H, Matsumura M, Fall KN, Prasad M, Ng VG, Sethi SS, Nazif TM, Parikh SA, Vahl TP, Ali ZA, Karmpaliotis D, Rabbani LE, Collins MB, Leon MB, McEntegart MB, Moses JW, Kirtane AJ, Mintz GS, Maehara A. Yamamoto K, et al. EuroIntervention. 2023 Aug 7;19(5):e383-e393. doi: 10.4244/EIJ-D-23-00107. EuroIntervention. 2023. PMID: 37283548 Free article.
BACKGROUND: Despite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechanism of ostial RCA ISR is not well understood. ...Primary ISR mechanisms were classified as follows: 1) neointimal hyperplasia (NIH); 2) neoa …
BACKGROUND: Despite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechan …
Current treatment of in-stent restenosis.
Alfonso F, Byrne RA, Rivero F, Kastrati A. Alfonso F, et al. J Am Coll Cardiol. 2014 Jun 24;63(24):2659-73. doi: 10.1016/j.jacc.2014.02.545. Epub 2014 Mar 13. J Am Coll Cardiol. 2014. PMID: 24632282 Free article. Review.
Management of patients with in-stent restenosis (ISR) remains an important clinical problem. Although drug-eluting stents (DES) have drastically reduced the incidence of ISR, treatment of DES-ISR is particularly challenging. ...In this paper, we systematically revie …
Management of patients with in-stent restenosis (ISR) remains an important clinical problem. Although drug-eluting stents (DES …
Stent failure: the diagnosis and management of intracoronary stent restenosis.
Protty MB, Dissanayake T, Jeffery D, Hailan A, Choudhury A. Protty MB, et al. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(7):501-506. doi: 10.1080/14779072.2023.2221852. Epub 2023 Jun 5. Expert Rev Cardiovasc Ther. 2023. PMID: 37269322 Review.
INTRODUCTION: Despite advances in stent technology for percutaneous coronary intervention (PCI) in the treatment of coronary disease, these procedures can be complicated by stent failure manifested as intracoronary stent restenosis (ISR). Even with adv …
INTRODUCTION: Despite advances in stent technology for percutaneous coronary intervention (PCI) in the treatment of coronary disease, …
Femoropopliteal in-stent restenosis: current treatment strategies.
Singh GD, Armstrong EJ, Laird JR. Singh GD, et al. J Cardiovasc Surg (Torino). 2014 Jun;55(3):325-33. J Cardiovasc Surg (Torino). 2014. PMID: 24755700 Review.
Nitinol self-expanding stents are increasingly used to treat symptomatic peripheral arterial disease. Despite reduction in procedural complications and rates of stent fracture, femoropopliteal in-stent restenosis (FP-ISR) remains a common and important clinic …
Nitinol self-expanding stents are increasingly used to treat symptomatic peripheral arterial disease. Despite reduction in procedural compli …
Sensors-based monitoring and treatment approaches for in-stent restenosis.
Yi Y, Wang B, Li C. Yi Y, et al. J Biomed Mater Res B Appl Biomater. 2023 Feb;111(2):490-498. doi: 10.1002/jbm.b.35164. Epub 2022 Sep 26. J Biomed Mater Res B Appl Biomater. 2023. PMID: 36161478 Review.
A popular treatment for the disease is to use an intravascular mechanical device called the stent to achieve an immediate restoration of blood flow. However, the physical stimulation induced by the stent expansion can cause inflammation of the vessel tissue. As one …
A popular treatment for the disease is to use an intravascular mechanical device called the stent to achieve an immediate restoration …
451 results